Merek & Company 13F Filing Shows Co Reported 1.214M-Share Position In Evaxion Valued At $3.76M
https://www.sec.gov/Archives/edgar/data/310158/000031015826000210/xslForm13F_X02/MerckInformationTableQ2.xml
Merck, a big medicine company, owns about 1.2 million shares of a smaller biotech company called Evaxion. This is just reporting what they own, like telling someone what's in your piggy bank—it shows Merck believes in Evaxion's work enough to invest in it.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.